KYMR vs GILD: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Gilead Sciences Inc in 2026
KYMR
Kymera Therapeutics Inc
—
GILD
Gilead Sciences Inc
$135.64
Key Metrics Comparison
| Metric | KYMR | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.39B | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze KYMR
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or GILD a better investment?
Comparing KYMR and GILD: Kymera Therapeutics Inc has a market cap of $7.39B while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and GILD?
KYMR (Kymera Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or GILD?
Both KYMR and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: KYMR or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: KYMR or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $7.39B for KYMR.
Should I buy KYMR or GILD in 2026?
Both KYMR and GILD have investment merit. KYMR trades at $N/A while GILD trades at $135.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and GILD stock?
Key differences: Market Cap ($7.39B vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy KYMR or GILD in 2026?
The choice between KYMR and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KYMR and GILD?
KYMR (Kymera Therapeutics Inc) has a market cap of $7.39B, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.